Meetings/Webinars/Learning Opportunities

The Division of Neuroscience at the National Institute on Aging

“Novel Tracers and Emerging Targets for Positron Emission Tomography in Alzheimer’s Disease and Related Dementias”

March 12 – 13, 2025 | Virtual Workshop

This workshop will bring together the complementary expertise of NIA-funded neurologists, pathologists, radiologists, chemists, and biologists to stimulate a discussion on the role of PET imaging in clinical practice, human research studies, and translational applications. Discussions will also include emerging PET tracers that show promise for use in AD/ADRD clinical research, including those targeting cellular pathways relevant in the neurodegenerative cascade, such as neuroinflammation, oxidative stress, mitochondrial function, protein homeostasis, and epigenetic regulation.

registration is required

---

Duke/UNC ADRC

Leveraging Existing Date and Methods in Health Disparities Research 2025

March 18 – 19, 2025 | JB Duke Hotel | Virtual

Learn how existing data resources paired with innovative applications and well-known methodologies can be used to identify valid and replicable population health trends and effects focused on multi-level societal, community, and individual determinants of health disparities in Alzheimer’s Disease and Related Dementias.

---

Duke/UNC ADRC REC Core

IDEAS Forum

Thursday, March 27, 2025 | 4pm | Virtual

Discussing the Rise of Machine Learning and AI in Data Analysis and Applications to Alzheimer’s Disease Research

Ramon Casanova, PhD

Professor, Biostatistics and Data Science, Wake Forest School of Medicine

---

DCNN & ADRC Progress in Neurodegeneration Research Symposium

Tuesday, April 8th | Semans Center, Duke University

A Scientific Symposium to bring together Duke’s neurodegenerative disease research community. Cash prizes for best abstracts! Dedicated time for ESI interaction with the external speakers. Registration and Abstracts must be submitted through the website.

6th Floor, Mary Duke Biddle Trent Semans Center for Health Education, Duke University

---

Kudos!

Congratulations to Clinical Core Leaders Kim Johnson, MD and Heidi Roth, MD on their recent publication which describes the start-up of the Duke and UNC lecanemab programs – Developing treatment models for the delivery of the anti-amyloid therapy, lecanemab: Considerations for implementation of lecanemab in healthcare systems. Weber M, Roth HL, Abramowitz A, Johnson KG. Am J Geriatr Psychiatry. 2025 Feb 26:S1064-7481(25) PMID: 40058984.

---

Two New Scientific Publications Ahead of APOLLOE4 Phase 3 Trial Topline Symposium at ADPD Conference

April 1 – 5, 2025 | Vienna, Austria

Alzheon will present the topline results of the pivotal APOLLOE4 Phase 3 trial at a dedicated symposium titled: “Inhibition of Beta Amyloid Oligomer Neurotoxicity with Oral Valiltramiprosate in APOE ε4/ε4 Homozygotes with Early Alzheimer’s Disease: Results of APOLLOE4 Phase 3 Trial”.

Valiltramiprosate symposium presentations will be made by multiple experts including Duke’s Murali Doraiswamy, MD

---

Save the Date!

Duke/UNC ADRC

ADRC 101

Tuesday, May 20, 2025 | 12:30pm | Virtual

ADRC information session featuring presentations by Center Directors:
Heather E. Whitson, MD, MHS & Gwenn A. Garden, MD, PhD

---

Coming in May

Duke/UNC ADRC RFA for Developmental Projects!